Thermo Fisher Scientific Income from Continuous Operations 2010-2025 | TMO

Thermo Fisher Scientific income from continuous operations for the twelve months ending March 31, 2025 was $6.518B, a 8.74% increase year-over-year.

  • Thermo Fisher Scientific annual income from continuous operations for 2024 was $6.338B, a 6.43% increase from 2023.
  • Thermo Fisher Scientific annual income from continuous operations for 2023 was $5.955B, a 14.44% decline from 2022.
  • Thermo Fisher Scientific annual income from continuous operations for 2022 was $6.96B, a 9.94% decline from 2021.

Thermo Fisher Scientific Income from Continuous Operations 2010-2025 | TMO

  • Thermo Fisher Scientific annual income from continuous operations for 2024 was $6.338B, a 6.43% increase from 2023.
  • Thermo Fisher Scientific annual income from continuous operations for 2023 was $5.955B, a 14.44% decline from 2022.
  • Thermo Fisher Scientific annual income from continuous operations for 2022 was $6.96B, a 9.94% decline from 2021.
Related Stocks
Company NameMarket
Cap
Intuitive Surgical (ISRG)$185B
Edwards Lifesciences (EW)$44.7B
Alcon (ALC)$42.9B
IDEXX Laboratories (IDXX)$41.7B
DexCom (DXCM)$33B
IQVIA Holdings (IQV)$28.2B
Mettler-Toledo (MTD)$25.1B
STERIS (STE)$22.1B
Waters (WAT)$17.7B
SONOVA HOLDING (SONVY)$17B
Hologic (HOLX)$14.3B
Sysmex ADR (SSMXY)$10.6B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.6B
Globus Medical (GMED)$7.8B
Glaukos (GKOS)$5.7B
Teleflex (TFX)$5B
Integer Holdings (ITGR)$4B
TransMedics (TMDX)$3.8B
PROCEPT BioRobotics (PRCT)$3.3B
LivaNova (LIVN)$2.3B
Nihon Kohden (NHNKY)$2B
Veracyte (VCYT)$1.9B
Elekta AB (EKTAY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1.1B
Tandem Diabetes Care (TNDM)$1B